下一代混合技术用于医药行业废水处理
M Vijay Pradhap Singh1, K Ravi Shankar2
1Department of Biotechnology, Vivekanandha College of Engineering for Women (Autonomous), Namakkal, Elayampalayam, Tiruchengode, Tamil Nadu, 637 205, India.
Journal of environmental management
|February 1, 2024
概括
药品污染水,对生态系统和人类健康构成风险. 本综述强调了混合和环保的生物修复技术,用于有效的制药废水处理.
科学领域:
- 环境科学 环境科学
- 水处理技术水处理技术
- 生态毒理学 生态毒理学
背景情况:
- 全球人口增长和城市化正在加剧淡水需求和污染.
- 药品,包括抗生素和NSAID,是水体中新出现的污染物.
- 这些污染物,即使在低度 (ng/mg) 中,也会破坏海洋生态系统,并对人类健康构成风险,例如生殖问题和癌症.
研究的目的:
- 审查用于制药废水处理的新兴混合技术.
- 分析传统和综合处理方法的优缺点.
- 讨论环保的生物修复策略,以消除制药污染物.
主要方法:
- 审查关于传统和混合废水处理技术的现有文献.
- 详细检查各种生物修复技术:生物刺激,生物增强,细菌降解,真菌修复和植物修复.
- 分析不同治疗方法的有效性和局限性.
主要成果:
- 传统方法在解决复杂的制药污染方面存在局限性.
- 混合技术为提高制药废水处理提供了巨大的潜力.
- 环保的生物修复技术显示出可持续的污染物去除的前景.
结论:
- 综合和有针对性的解决方案对于管理制药污染至关重要.
- 混合技术与生物修复相结合,代表了制药废水处理的有希望的未来.
- 对这些先进方法的进一步研究对于环境保护至关重要.
更多相关视频
05:46Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
Published on: August 1, 2018
13.1K
07:34Author Spotlight: Scaling Microalgal Biotechnology for Enhanced Biomethane Production
Published on: March 22, 2024
2.5K
相关概念视频
Bioremediation
18.4K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
18.4K
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Enhanced Elimination of Poison
513
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
513
